ADC Therapeutics S.A.ADCTNYSE
LOADING
|||
Switch Symbol:
Operating Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year operating income growth rate
Latest
29.85%
↑ 249% above average
Average (30q)
-20.08%
Historical baseline
Range
High:95.51%
Low:-367.59%
Volatility
-2306.1%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 29.85% |
| Q2 2025 | -55.10% |
| Q1 2025 | 12.25% |
| Q4 2024 | 8.80% |
| Q3 2024 | -22.46% |
| Q2 2024 | 13.60% |
| Q1 2024 | 15.92% |
| Q4 2023 | -6.88% |
| Q3 2023 | 5.66% |
| Q2 2023 | 21.03% |
| Q1 2023 | -367.59% |
| Q4 2022 | -244.83% |
| Q3 2022 | 95.51% |
| Q2 2022 | -71.96% |
| Q1 2022 | 35.71% |
| Q4 2021 | -8.63% |
| Q3 2021 | 18.00% |
| Q2 2021 | 0.26% |
| Q1 2021 | 9.41% |
| Q4 2020 | -48.78% |
| Q3 2020 | -16.64% |
| Q2 2020 | -2.42% |
| Q1 2020 | -22.82% |
| Q4 2019 | -8.80% |
| Q3 2019 | -37.49% |
| Q2 2019 | 6.00% |
| Q1 2019 | 18.63% |
| Q4 2018 | 0.00% |
| Q3 2018 | 1.24% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |